Jun 8, 2026 08:00AM
Jun 1, 2026 08:18AM
May 19, 2026 04:01PM
May 19, 2026 04:01PM
May 7, 2026 04:05PM
Apr 23, 2026 04:30PM
Apr 23, 2026 04:30PM Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
Apr 17, 2026 08:31AM
Apr 17, 2026 08:30AM
Mar 12, 2026 04:05PM
Jan 15, 2026 08:00AM
Nov 13, 2025 04:05PM
Nov 5, 2025 04:00PM
Nov 5, 2025 04:00PM Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Sep 10, 2025 04:55PM
Sep 10, 2025 04:54PM
Aug 13, 2025 04:05PM
Jun 11, 2025 07:30AM
Jun 11, 2025 07:30AM
May 27, 2025 08:00AM
May 15, 2025 08:01AM Vaxart (VXRT) Receives BARDA Approval to Initiate Dosing in 10,000-Participant Portion of Phase 2b COVID-19 Trial
May 15, 2025 08:00AM
May 14, 2025 04:05PM
May 13, 2025 04:05PM
May 13, 2025 04:02PM
May 13, 2025 04:01PM
Apr 30, 2025 08:01AM
Apr 30, 2025 08:00AM Vaxart Completes Enrollment in Phase 1 Trial for its Norovirus Oral Pill Vaccine Candidate
Mar 20, 2025 04:01PM
Mar 11, 2025 08:00AM
Mar 5, 2025 04:06PM
Mar 5, 2025 04:05PM
Jan 28, 2025 08:02AM
Jan 28, 2025 08:00AM
Jan 14, 2025 08:07AM Vaxart (VXRT) Highlights Progress of COVID-19, Norovirus and Influenza Programs
Jan 14, 2025 08:00AM
Jan 13, 2025 07:55PM
Dec 2, 2024 04:01PM
Nov 13, 2024 04:01PM
Sep 30, 2024 04:12PM
Aug 28, 2024 08:01AM
Aug 28, 2024 08:00AM Vaxart Announces Publication in Vaccines of Preclinical Data Supporting the Potential of its Mucosal Vaccine Technology Platform in Enabling Therapeutic Vaccination for HPV-Related Cervical Dysplasia
Aug 8, 2024 04:01PM
Jun 17, 2024 04:06PM
Jun 17, 2024 04:05PM
Jun 13, 2024 04:15PM
Jun 13, 2024 04:15PM
May 13, 2024 04:01PM
Apr 30, 2024 08:01AM Vaxart (VXRT) Reports Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
Apr 30, 2024 08:00AM

323,009 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All